InsiderEdge™ – Top Sales and Top Purchases – July 03, 2024

Top Purchases

The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.

No top purchases today.


Top Sales

The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.

Director at Arcutis Biotherapeutics, Inc. ($ARQT)

The Director sold 10,000 shares at $9.31/share ($93,141.00 total) which decreased their vested holdings by 4.5%. The current price is $9.30 (-0.2%). Their median sale size is $69,933.40 and this is their 10th largest sale out of 30 all time. (SEC Source)

Historic Returns
1m returns: -7% weighted | -8% median | 29% win rate (8/28)
3m returns: -11% weighted | -10% median | 21% win rate (6/28)
6m returns: -23% weighted | -19% median | 25% win rate (7/28)
1y returns: -38% weighted | -30% median | 14% win rate (4/28)


Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.

Related Posts
BBAE Blueprint

BBAE: Up to $400 First Deposit Bonus!

Tailored insights, powerful tools. Automatic bonus at signup.
Get Started with BBAE Now!